4//SEC Filing
Xynos Konstantinos 4
Accession 0001104659-25-052145
CIK 0001737953other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:46 PM ET
Size
5.6 KB
Accession
0001104659-25-052145
Insider Transaction Report
Form 4
Xynos Konstantinos
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-05-20$8.06/sh−7,952$64,093→ 146,933 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $8.05 to $8.80 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001956241
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 9:46 PM ET
- Size
- 5.6 KB